Literature DB >> 447848

Inhibition of intrapituitary thyroxine to 3.5.3'-triiodothyronine conversion prevents the acute suppression of thyrotropin release by thyroxine in hypothyroid rats.

P R Larsen, T E Dick, B P Markovitz, M M Kaplan, T G Gard.   

Abstract

Iopanoic acid has been shown to block thyroxine (T4)-5'-monodeiodination in rat anterior pituitary in vitro. To test the hypothesis that the acute decrease in thyrotropin (TSH) after infusion of T4 into hypothyroid rats requires intrapituitary T4 to 3,5,3'-triiodothyroxine (T3) conversion, the effect of iopanoic acid treatment on the generation of nuclear T3 from intrapituitary conversion and the response to TSH were compared in control and iopanoic acid-treated animals. 5 mg/100 g body weight iopanoic acid given 24, 16, and 1.5 h before administration of 125I-T4 reduced the quantity of pituitary nuclear 125I-T3 from local (intrapituitary) T4 to T3 conversion by 60-100%. In association with inhibition of intrapituitary T4 to T3 conversion, there was an increase in the binding of 125I-T4 to the nuclear receptor of the pituitary but the total iodothyronine content of the nuclei was still less than half of the nuclear iodothyronine in control animals. Iopanoic acid did not affect the nuclear/plasma ratio of injected 131I-T3 in the same animals, but did appear to impair 131I-T3 clearance or reduce its distribution volume. Treatment with iopanoic acid did not reduce the quantity of nuclear 125I-T3 in the liver, kidney, or heart of the same animals more than expected from the changes in serum 125I-T3. In control hypo-thyroid animals pretreated with iopanoic acid, the mean TSH was not significantly decreased from the initial value by T4 injection. Iopanoic acid pretreatment did not interfere with the acute TSH response of chronically hypothyroid rats to 70 ng of T3/100 g body weight. These results establish that intrapituitary generations of T3 from T4 is required for the acute decrease in TSH which occurs after T4 infusion. The data also are consistent with the content that it is nuclear binding of the T3 generated from T4 which initiates the inhibition of TSH release.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447848      PMCID: PMC372097          DOI: 10.1172/JCI109430

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Influence of propylthiouracil on the thyroxine-thyrotropin interplay.

Authors:  G M JAGIELLO; J M McKENZIE
Journal:  Endocrinology       Date:  1960-10       Impact factor: 4.736

2.  A practical method for plasma albumin turnover studies.

Authors:  J D PEARSON; N VEALL; H VETTER
Journal:  Strahlentherapie       Date:  1958

3.  Normal I-131 L-thyroxine metabolism in the presence of potassium perchlorate and interrupted by propylthiouracil.

Authors:  S L JONES; L VAN MIDDLESWORTH
Journal:  Endocrinology       Date:  1960-12       Impact factor: 4.736

4.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

5.  Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, liver, and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptors and the acute inhibition of thyroid-stimulating hormone release.

Authors:  J E Silva; P R Larsen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.

Authors:  J E Silva; T E Dick; P R Larsen
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

7.  Effect of starvation, nutriment replacement, and hypothyroidism on in vitro hepatic T4 to T3 conversion in the rat.

Authors:  A R Harris; S L Fang; A G Vagenakis; L E Braverman
Journal:  Metabolism       Date:  1978-11       Impact factor: 8.694

8.  Peripheral metabolism of homologous thyrotropin in euthyroid and hypothyroid rats: acute effects of thyrotropin-releasing hormone, triiodothyronine, and thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1978-06       Impact factor: 4.736

9.  Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Science       Date:  1977-11-11       Impact factor: 47.728

10.  Isolation of labeled triiodothyronine from serum using affinity chromatography: application to the extimation of the peripheral T4 to T3 conversion in rats.

Authors:  C J Zimmerman; M Izumi; P R Larsen
Journal:  Metabolism       Date:  1978-03       Impact factor: 8.694

View more
  33 in total

1.  Acute decrease in circulating T3 levels enhances, but does not normalise, the GH response to GHRP-6 plus GHRH in thyrotoxicosis.

Authors:  S O Nascif; M H Senger; J C Ramos-Dias; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

2.  Influence of type II 5' deiodinase on TSH content in diabetic rats.

Authors:  C Aláez; R Calvo; M J Obregón; C Alvarez; L Goya; F Escrivá; M A Martín; A M Pascual-Leone
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

Review 3.  Bioenergetic impact of tissue-specific regulation of iodothyronine deiodinases during nutritional imbalance.

Authors:  Renata L Araujo; Denise P Carvalho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

4.  The effect of benziodarone on the thyroid hormone levels and the pituitary-thyroid axis.

Authors:  B Xanthopoulos; D A Koutras; M A Boukis; G D Piperingos; J Kitsopanides; A Souvatzoglou; S D Moulopoulos
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  Thyroid, renal, and hepatic function tests following cholecystography with high-dose contrast agents.

Authors:  R G Reiner; M J Lawson; J Marshall; T R Read; C G Beng; G T Davies; W G Tucker; A K Grant
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

6.  Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.

Authors:  R R Ghose; H P Upadhyay
Journal:  Postgrad Med J       Date:  1986-01       Impact factor: 2.401

7.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Evidence for two tissue-specific pathways for in vivo thyroxine 5'-deiodination in the rat.

Authors:  J E Silva; J L Leonard; F R Crantz; P R Larsen
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

9.  Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat.

Authors:  S L Abend; S L Fang; S Alex; L E Braverman; J L Leonard
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

10.  Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man.

Authors:  S M Lum; J T Nicoloff; C A Spencer; E M Kaptein
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.